StockData
Coherus Oncology, Inc. logo

Coherus Oncology, Inc. (CHRS) stock

CHRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3059% below fair value
$0.48−0.03 (-5.42%)

Close on Nov 17, 2026Market cap $73.93MP/E –Yield –

Coherus Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Coherus Oncology's market cap was $89.98M on Nov 11, 2026, against $158.08M a year earlier. Over the last 5 years it ranged from $84.76M to $1.22B, with a median of $232.41M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$89.98M-45.5%
2025Dec 31, 2025$165.06M+3.8%
2024Dec 31, 2024$158.99M-56.2%
2023Dec 29, 2023$363.35M-41.0%
2022Dec 30, 2022$615.94M-49.6%
2021Dec 31, 2021$1.22B-13.4%
2020Dec 31, 2020$1.41B+5.7%
2019Dec 31, 2019$1.33B+135.7%
2018Dec 31, 2018$566.38M+29.7%
2017Dec 29, 2017$436.55M-63.6%
2016Dec 30, 2016$1.20B+57.0%
2015Dec 31, 2015$763.60M+911.8%
2014Dec 31, 2014$75.47M–

More Coherus Oncology figures

See a number that looks wrong?